MMP1-1607(1G>2G) polymorphism and the risk of lung cancer in Lebanon

Annals of Thoracic Medicine

Volumn 7, Issue 3, 2012, Pages 130-132

  Fakhoury, Hana ^a   Noureddine, Sara ^b   Chmaisse, Hania N ^b   Tamim, Hani ^b   Makki, Rajaa F ^c  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c BEIRUT ARAB UNIVERSITY   (Lebanon)

Author keywords

Lebanon; lung cancer; MMP1; polymorphism

Indexed keywords

GENOMIC DNA; INTERSTITIAL COLLAGENASE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LEBANON; LUNG CANCER; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84864713093     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.98844     Document Type: Article

References (15)

1. Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6:4823-30.
2. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.
3. Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets. Int J Cancer 2002;99:157-66.
4. Ye S, Dhillon S, Turner SJ, Bateman AC, Theaker JM, Pickering RM, et al. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 2001;61:1296-8.
5. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5.
6. Shamseddine A, Sibai AM, Gehchan N, Rahal B, El-Saghir N, Ghosn M, et al. Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Ann Epidemiol 2004;14:663-8.
7. Shamseddine AI, Musallam KM. Cancer Epidemiology in Lebanon. Middle East J Cancer 2010;1:41-4.
8. Waked M, Salameh P, Aoun Z. Water-pipe (narguile) smokers in Lebanon: A pilot study. East Mediterr Health J 2009;15:432-42.
9. Saade G, Warren CW, Jones NR, Asma S, Mokdad A. Linking Global youth tobacco survey (GYTS) data to the WHO Framework convention on tobacco control (FCTC): The case for Lebanon. Prev Med 2008;47 Suppl 1:S15-9.
10. Shihadeh A, Saleh R. Polycyclic aromatic hydrocarbons, carbon monoxide, 'tar', and nicotine in the mainstream smoke aerosol of the narghile water pipe. Food Chem Toxicol 2005;43:655-61.
11. Monzer B, Sepetdjian E, Saliba N, Shihadeh A. Charcoal emissions as a source of CO and carcinogenic PAH in mainstream narghile waterpipe smoke. Food Chem Toxicol 2008;46:2991-5.
12. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001;61: 7825-9.
13. Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 2005;26:481-6.
14. Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G, et al. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:567-70.
15. Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, et al. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: A meta-analysis of 50 case-control studies. Mutagenesis 2010;25:41-8.